| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.00053 | 1 |